Medline (MDLN) Accumulated Depreciation & Amortization (2024 - 2025)

Medline (MDLN) reported Accumulated Depreciation & Amortization of $1.0 billion for Q4 2025, up 3.48% year-over-year from $977.0 million in Q4 2024, and up 3.48% on a QoQ basis from $977.0 million in Q4 2024.

Medline (MDLN) has 2 years of Accumulated Depreciation & Amortization data on file, last reported at $1.0 billion in Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 3.48% year-over-year to $1.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 billion (up 3.48% YoY) and the FY2025 annual result came in at $1.0 billion, up 3.48% from the prior year.
  • Accumulated Depreciation & Amortization improved to $1.0 billion in Q4 2025 per MDLN's latest filing, from $977.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.0 billion in Q4 2025 and bottomed at $977.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 146.28 Bn 141.88 Bn 1.83 Bn
2 Becton Dickinson 41.14 Bn 40.13 Bn 2.15 Bn
3 Medline 29.16 Bn 35.00 Bn 1.84 Bn
4 Resmed 27.13 Bn 25.47 Bn 890.98 Mn
5 West Pharmaceutical Services 22.71 Bn 22.19 Bn 296.40 Mn
6 Solventum 13.26 Bn 13.26 Bn 1.10 Bn
7 Align Technology 12.22 Bn 11.16 Bn 736.59 Mn
8 Cooper Companies 11.79 Bn 11.66 Bn 695.20 Mn
9 Baxter International 9.47 Bn 7.42 Bn 891.00 Mn
10 Aptargroup 7.19 Bn 6.99 Bn 351.91 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.01 Bn
Dec 31, 2025 1.01 Bn
Dec 31, 2024 977.00 Mn
Dec 31, 2024 977.00 Mn